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Giulia Miglietta1,*, Susanna Cogoi1,*, Erik B. Pedersen2 & Luigi E. Xodo1
HRAS is regulated by two neighbouring quadruplex-forming GC-elements (hras-1 and hras-2), 
located upstream of the major transcription start sites (doi: 10.1093/nar/gku 5784). In this study 
we demonstrate that the C-rich strands of hras-1 and hras-2 fold into i-motif conformations (iMs) 
characterized under crowding conditions (PEG-300, 40% w/v) by semi-transitions at pH 6.3 and 6.7, 
respectively. Nondenaturing PAGE shows that the HRAS C-rich sequences migrate at both pH 5 and 7 as 
folded intramolecular structures. Chromatin immunoprecipitation shows that hnRNP A1 is associated 
under in vivo conditions to the GC-elements, while EMSA proves that hnRNP A1 binds tightly to the iMs. 
FRET and CD show that hnRNP A1 unfolds the iM structures upon binding. Furthermore, when hnRNP 
A1 is knocked out in T24 bladder cancer cells by a specific shRNA, the HRAS transcript level drops to 
44 ± 5% of the control, suggesting that hnRNP A1 is necessary for gene activation. The sequestration 
by decoy oligonucleotides of the proteins (hnRNP A1 and others) binding to the HRAS iMs causes a 
significant inhibition of HRAS transcription. All these outcomes suggest that HRAS is regulated by a 
G-quadruplex/i-motif switch interacting with proteins that recognize non B-DNA conformations.
The HRAS oncogene encodes for a 21-kD GTP-ase conveying signals to the nucleus that stimulate cell prolifer-
ation1. In many tumours HRAS is mutated, normally in exon 1, codon 12, 13 or 61, and encodes for an altered 
protein which constitutively activates downstream pathways causing normal cells to become cancerous cells2. In 
previous works, we have demonstrated that HRAS is regulated by two neighbouring GC-rich elements that we 
called hras-1 (nt 432-464, A.N. J00277) and hras-2 (nt 509-530, A.N. J00277), located immediately upstream of 
the major transcription start sites (TSS’s), each capable of folding into a G-quadruplex structure3,4. By site-directed 
mutagenesis of the GC-elements, we found that the G-quadruplexes behave as transcription repressors3. Under 
normal conditions, hras-1 and hras-2 are folded into G-quadruplexes, thus locking the promoter into an inactive 
state characterized by a low transcription level3. Transcription is activated when the G-quadruplexes are unfolded, 
and the G-elements transformed into canonical B-DNA forms. We found that MAZ, a zinc-finger transcription 
factor recognizing blocks of guanines, interacts with the promoter GC-elements under cellular conditions3. MAZ 
is an essential protein for gene expression, as it unfolds the HRAS G-quadruplexes and activates transcription3,4. 
Our data support a transcription model according to which the two neighbouring G-quadruplexes behave as a 
molecular switch that controls gene expression.
In the present work we interrogated if the complementary C-rich strands of hras-1 and hras-2 (namely hras-
1Y and hras-2Y) fold into the well known iM conformation5–15. We found that hras-1Y and hras-2Y assume the iM 
conformation under slightly acidic conditions, which are close to neutrality in the presence of a crowding agent, for 
example PEG-30016. We also discovered that the HRAS iMs are recognized by nuclear proteins, including nuclear 
factor hnRNP A1. This protein, which shows a binding preference for cytosines, unfolds the iM conformation of 
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the HRAS sequences. When hnRNP A1 was knocked out in T24 bladder cancer cells by a specific shRNA, the level 
of HRAS transcript also dropped to 44 ± 5% of the control. Together, our data provide evidence that hnRNP A1, 
with its unfolding activity against the iM, is an essential factor for the activation of HRAS. Indeed, when hnRNP 
A1 was sequestered by decoy oligonucleotides mimicking the iM, HRAS transcription was significantly down-
regulated. The outcome of this work support the notion that HRAS expression is regulated by a G-quadruplex/iM 
switch that is controlled by proteins.
Results and Discussion
The sequence of the HRAS promoter immediately upstream of the major transcription start sites is reported in 
Fig. 1A. It contains two GC-rich elements, hras-1 and hras-2, composed of blocks of guanines and capable of folding 
into G-quadruplex structures. In previous works we have demonstrated that these sequences behave as a regulatory 
switch controlling gene expression3,4. Such a mechanism has been proposed for other relevant oncogenes including 
KRAS17,18, CKIT19,20, and CMYC21,22. A couple of comprehensive reviews on this subject have been reported23,24. 
In this work we have focused on the complementary C-rich strands hras-1Y and hras-2Y and have investigated if 
they fold into stable iMs.
iM formation by the HRAS C-rich sequences. To find out if hras-1Y and hras-2Y can assume the iM 
conformation, we performed circular dichroism (CD) experiments as a function of pH, in 50 mM KCl, 50 mM 
Tris-acetate, 25 °C. To mimic the crowding conditions of the cell, we analysed the sequences both in the presence 
and absence of 40% (w/v) PEG-30016. Typical CD titrations are shown in Fig. 1B,C. It can be seen that the spectra 
of hras-1Y and hras-2Y change dramatically as the pH is gradually decreased from 8 to 4.5. Under acidic condi-
tions (pH 5) both sequences exhibit the characteristic enhanced ellipticity at ~287 nm of a classical iM10,12,25–27, 
while at pH 8 the sequences exhibit a much lower ellipticity, shifted at ~285 nm. By plotting the 287-nm ellipticity 
as a function of pH, we obtained for each sequence, in the presence or absence of PEG-300, sigmoidal curves 
reflecting iM formation (Fig. 1D). The crowding agent drives the folding at higher pH values: the semi-transition 
of hras-1Y increases from pH 5.9 to 6.3, whereas that of hras-2Y increases from pH 6.2 to 6.7. These plots suggest 
that the iMs are stable in a slightly acidic medium. However, under cellular conditions the iM can be stabilized by: 
Figure 1. (A) Sequences of the GC-rich elements located in the HRAS promoter upstream of major TSS’s; (B,C) 
Circular dichroism titrations of hras-1Y and hras-2Y (3 μ M, 1 cm pathlength cell) in 50 mM Tris-acetate, 50 mM 
KCl, 40% PEG-300 and pH from 4.5 to 8; (D) Ellipticity (287 nm) versus pH curves for hras-1Y and hras-2Y in 
the presence and absence of PEG-300; (E) Determination of number of protons picked up by hras-1Y and hras-
2Y upon folding into the iM.
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(i) transcriptionally induced DNA superhelicity28,29; (ii) more effective cellular crowding conditions30,31; (iii) an 
increased intracellular acidity generated by an increase of the glucose-lactate flux32,33.
As the ellipticity-versus-pH curves are reversible, we evaluated the number of protons involved in the folding 
of hras-1Y and hras-2Y, by considering the following equilibria:
+ ⋅ ( )+ + ⁎mH U U mH 1
⋅ + ⋅ ( + ) ( )+ + +⁎U mH nH F m n H 2
where equilibrium 1 takes into consideration the fact that the unfolded C-rich sequence, U, may bind m protons 
before folding into the i-motif (as the pKa of cytosine is ∼ 4.434, at pH 5 about 3 cytosines out of 12 are expected 
to be protonated); U*·mH+ is the unfolded sequence with m bound protons. The bases in U*·mH+ are assumed 
to be unstacked, so the formation of this species is accompanied by a negligible change in the CD spectrum35. In 
contrast, upon folding into i-motif F, U*·mH+ assumes in a cooperative manner other n protons to form (n+ m) 
CH+:C base pairs that are stacked in the structure. A significant CD spectral change is expected for the formation 
of the iM8,10 (equilibrium 2), whose equilibrium constant is KD = ([F·(m+ n)H+]/([U*·mH+][H+]n) (3). From 
the CD plots of Fig. 1B,C, we determined for each sequence the fraction of folded and unfolded species and ratio 
[F(n+m)H+]/[ U*·mH+]. By plotting log [F(n+m)H+]/[ U*·mH+] versus pH, we obtained a straight line whose 
slope is n (Fig. 1E). We obtained values of n ∼ 4 and n ∼ 2 for hras-1Y and hras-2Y, respectively. This suggests that 
when hras-1Y and hras-2Y fold into the iM, they assume 4 and 2 protons, respectively, which agrees with the fact 
that the sequences are partially protonated before folding. A similar behaviour has been previously observed for 
the formation of the i-motif by (C3TA2)414.
PAGE and analyses of melting curves. The intramolecular iM, being a folded structure, migrates in a 
polyacrylamide gel faster than an unfolded oligonucleotide of the same length. We analysed hras-1Y and hras-2Y by 
PAGE under different pH conditions. The mobility of the two C-rich sequences was compared with that of hras-1Y 
variants: ODN-1 (unable to form any structure); ODN-2 (forming an iM with 4 CH+:C) and ODN-3 (forming a 
stable W.C. hairpin) (Fig. 2A,B) (Methods). Under denaturing conditions (7 M urea), the 27-mer oligonucleotides 
(hras-1Y and variants) exhibited the same mobility, with the exception of ODN-3 that forms a hairpin even in the 
presence of 7 M urea. Sequence hras-2Y, being embedded in a 36-mer oligonucleotide, migrates slowly (Methods). 
In contrast, under native conditions at pH 5, hras-1Y, that assumes the iM according to CD, migrates with a sharp 
band faster than that of ODN-1. Interestingly, when the hras-1Y sequence is modified to fold into a hairpin stabilized 
by a stem of 8 W.C. bps (ODN-3) (S1), it migrates even quicker than the iM. This is because the 6 positive charges 
of iM reduce its negative charge density. The folding of hras-1Y into the iM is quite fast, as the mobility does not 
change when the sample is heated before loading. Variant ODN-2, forming an iM with 4 positive charges (S1), 
migrates slightly faster than hras-1Y, as expected. At pH 5, the 36-mer oligonucleotide containing sequence hras-2Y 
migrates quicker than unstructured 27-mer ODN-1, as it folds into the iM (see CD). At pH 7, both hras-1Y and 
hras-2Y still migrate faster than ODN-1, indicating that even at neutral pH the sequences are folded. However, they 
Figure 2. (A) PAGE of hras-1Y and hras-2Y and variants ODN-1, ODN-2 and ODN-3 in denaturing conditions 
(7 M urea); native conditions at pH 5 and 7. The oligonucleotide sequences are reported in Methods. The 
electrophoresis was run at 20 °C, the bands stained with stains-all. Δ = heated 10 min 90 °C; (B) CH+:C base 
pair; (C) Putative equilibrium between iMs involving different protonation levels and a flexible hairpin formed 
by hras-1Y at pH ≥ 7.
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migrate either with a smeared band (hras-1Y) or with two bands (hras-2Y), suggesting that more than one folded 
structure is formed: most likely iM-like structures stabilized by C:C and CH+:C bps. It is also possible that at pH 
7, the iM-like structure is in equilibrium with a flexible hairpin (Fig. 2C, S1).
We have also examined the thermal stability of the iMs by CD- and FRET-melting experiments. Typical 
CD-melting profiles for hras-1Y and hras-2Y are reported in Fig. 3A,B. By heating (20 → 85 °C) and then cooling 
(85 → 20 °C) the DNA solutions in 50 mM sodium cacodylate, pH 5, 50 mM KCl, the folded/unfolded transitions 
showed to be cooperative and reversible, as previously found for C-rich oligonucleotides under similar experi-
mental conditions10,12–14. The melting in the pH range between 5 and 7 was examined by FRET experiments, using 
oligonucleotides end-labelled with ATTO-488 (5′ -end) and TAMRA (3′ -end) (Fig. 3C,D). The TM of both hras-1Y 
and hras-2Y decreased with increasing pH: hras-1Y, 55.9, 52.1, 47.6, 44.8, 41.3 °C at pH 5, 5.5, 6, 6.5, 7, respec-
tively; hras-2Y, 65.5, 58.7, 55.1, 53.8, 53.1 °C at pH 5, 5.5, 6, 6.5, 7. At pH values > 5, the TM of the iMs decreases 
as the structure is probably stabilized by a number of CH+:C < 6. It is indeed reasonable to assume that when the 
medium is not sufficiently acidic, the iM is stabilized by both C:C and CH+:C base pairs36,37. iM structures of dif-
ferent protonation levels may coexist in solution. Mechanical stability experiments with the ILPR C-rich sequence 
showed that partially folded iM-like species are in equilibrium with fully folded iM at neutral pH36. The higher TM 
of hras-2Y is likely due to the additional CH+:C bp that stabilizes the iM. The two structures have similar rupture 
forces and sufficient stability to stall RNA polymerase36. Yang and Rodgers have reported that the energy of C:C 
is about 1/3 of that of CH+:C38. Sequence hras-2Y shows a behaviour similar to hras-1Y, with the difference that at 
pH 5 it shows a higher TM, 65.5 °C (Fig. 3D).
We evaluated the thermodynamics of the folding transitions according to a two-state model. This was 
done at pH 5, where the two sequences fold into only one structure, as shown by PAGE. From the CD- and 
FRET-melting curves at pH 5, we obtained the following average thermodynamic data (± 10%): Δ H = 252 kJ/mol 
and Δ S = − 770 J/mol K and Δ G = − 17 kJ/mol for hras-1Y; Δ H = 323 kJ/mol and Δ S = − 950 J/mol K and 
Δ G = − 27 kJ/mol for hras-2Y. Assuming that the breaking of a CH+:C bp needs approximately 46 ± 4 kJ/mol12, 
the number of CH+:C broken by the thermal disruption of hras-1Y is ~6, of hras-2Y is ~7, in accord with the number 
of expected protons that should bind to the sequences at pH near pKa10,12. At pH 5, nearly half of the cytosines is 
protonated and the sequences are completely folded into iM, showing the highest stability.
The HRAS iMs are recognized by hnRNP A1. As the iM-forming sequences overlap critical GC-elements 
immediately upstream of TSS, we interrogated if these unusual structures are recognized by nuclear proteins. 
Previous studies have reported that DNA sequences composed by runs of cytosines such as the C-repeats in the 
telomeres and in the CMYC promoter are recognized by proteins of the heterogeneous nuclear riboproteins fam-
ily (hnRNP)39,40 Moreover, Hurley and co-workers recently reported that the iM formed in the BCL2 promoter 
interacts with hnRNP LL6. Specific binding of heterogeneous ribonuclear proteins to C-rich DNA sequences is 
Figure 3. (A,B) CD melting curves of 3 μ M hras-1Y and hras-2Y in 50 mM sodium cacodylate, pH 5, 50 mM 
KCl. Denaturing curve (20 → 85 °C), renaturing curve (85 → 20 °C); (C,D) Fraction of iM versus T curves 
obtained from FRET-melting experiment (0.3 °C/min), in 50 mM sodium cacodylate, pH 5 to 7, 50 mM KCl. 
The curves of hras-1Y and hras-2Y at pH 5 are fully reversible. FRET-melting gives TM values ∼ 3 °C higher than 
CD-melting values, due to the presence of the fluorophores in the oligonucleotides analysed by FRET.
www.nature.com/scientificreports/
5Scientific RepoRts | 5:18097 | DOI: 10.1038/srep18097
also supported by previous work, according to which hnRNP A1 binds to the GC-element of KRAS17, which shows 
a high sequence/functional homology with the HRAS GC-elements. HnRNP A1 is one of the most abundant 
nuclear proteins of eukaryotic cells that regulates several aspects of mRNA biogenesis41. As it is over-expressed 
in a variety of cancers41,42, we wondered if this protein plays a role in the promoter of the HRAS oncogene, in the 
region where the iM can potentially be formed. To address this question, we first investigated by chromatin immu-
noprecipitation (ChIP) if in HRAS-mutant T24 bladder cancer cells, hnRNP A1 is associated to the GC-elements 
under in vivo conditions. The occupancy of hras-1 and hras-2 (located 6 bp upstream of first TSS) by hnRNP A1 
was compared with the occupancy of a reference GC-rich sequence unable to fold into a non-B DNA structure 
(located 870 bp downstream from first TSS). A typical ChIP is shown in Fig. 4A. We found that the occupancy of 
hras-1 and hras-2 by hnRNP A1 was, respectively, ~6- and ~5-fold higher than the occupancy by IgG (negative 
control). As hras-1 and hras-2 are located in the region of the major transcription start sites, they show a signif-
icant occupancy by RNA Pol II: ~4-fold higher than the IgG signal. In contrast, the reference sequence showed 
almost no occupancy by any of the proteins considered. The ChIP data provided strong evidence that hnRNP A1, 
under in vivo conditions, is indeed associated to the critical GC-elements of the HRAS promoter. However, ChIP 
data do not provide information about the conformation of the GC-elements interacting with hnRNP A1. To 
know if the nuclear factor recognizes the iM, we performed EMSA at pH 5.5 and 20 °C of mixtures composed by 
hras-1Y or hras-2Y and recombinant hnRNP A1, which was produced with a high degree of purity (Fig. 4B,C). It 
Figure 4. (A) ChIP experiment to determine the occupancy of hras-1, hras-2 and control sequence (870 bp 
downstream from TSS) by hnRNP A1. Histograms shows the relative occupancy of hras-1 and hras-2 by hnRNP 
A1, RNA Pol II (positive control) and IgG (negative control). Data have been normalized by IgG signal; (B) 
EMSA of 32P-labelled hras-1Y and hras-2Y in 50 mM Tris-acetate pH 5.5, 50 mM KCl, incubated 40 min at room 
temperature with increasing amounts of recombinant hnRNP A1 (0–12 μ g). Lane (Δ ,A1) indicates the iM 
incubated 40 min at room temperature, with denatured hnRNPA1 in binding buffer (see Methods); (C) EMSA 
at pH 5.5 of hras-1Y with BSA or denatured hnRNP A1 and EMSA of hras-1Y (m) with hnRNP A1; ss = single-
stranded oligonucleotide; 1:1 and 1:2 DNA-protein complexes.
www.nature.com/scientificreports/
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can be seen that at pH 5.5 hras-1Y and hras-2Y (which are in the folded iM conformation) form with hnRNP A1 a 
retarded band due to a 1:1 DNA-protein complex. In the presence of 4 μ g hnRNP A1, the iM is completely bound 
to the protein (Fig. 4B). With higher protein amounts, a second retarded band of much weaker intensity, probably 
a 1:2 complex, can be seen in the gel. When hnRNP A1 was thermally denatured before being added to the iM, 
the DNA-protein complex was abrogated and the iM migrated as a free molecule. As a further control, we used 
an unspecific protein like BSA and we found that it did not bind to the iM, as expected (Fig. 4C). When the iMs 
was destabilized by replacing 4 C with 4 T (hras-1Y(m)) (see Methods), the binding was significantly attenuated, 
suggesting that the iM conformation is essential for optimal hnRNP A1 binding.
hnRNP A1 unfolds the HRAS i-motif. In a previous work we have found that the HRAS promoter is highly 
active when the GC-elements are unfolded in the double-stranded conformation3,4. We now asked if the binding 
of hnRNP A1 to the iM involves the unfolding of this non B-DNA structure. To this purpose, we performed FRET 
experiments with hras-1Y tagged with ATTO-488 (donor) and TAMRA (acceptor) in 50 mM sodium cacodylate, pH 
5.5, 50 mM KCl. By exciting the donor at 480 nm, both donor (520 nm) and acceptor (580 nm) emit fluorescence, 
as a result of FRET between the fluorophores (Fig. 5A). When hras-1Y is folded into the iM, the energy transfer, 
ET, between the two fluorophores is 0.77, and their end-to-end distance is ∼ 40 Å (S2). The effect of hnRNP A1 on 
the iM was investigated by incubating protein and DNA for 1.5 h and measuring the fluorescence between 500 and 
650 nm, upon donor excitation at 480 nm. It can be seen that hnRNP A1 causes a dramatic increase of the donor 
emission, accompanied by a decrease of ET as a function of r (r = [protein]/[iM]), in a dose-dependent manner, 
from 0.77 (r = 0) to 0.18 (r = 7) (inset). This means that the end-to-end distance in the iM increases from ~40 to 
~64 Å, suggesting that upon binding to the protein, hras-1Y goes through a conformational change. When hras-
1Y is in the duplex conformation, the fluorophores are separated by ~86 Å (26 × 0.33 = 86 Å, where 0.33 Å is the 
vertical rise per bp), as a 27-mer duplex behaves as an extended rigid rod. It follows that the iM bound to hnRNP 
A1 is not fully extended as in the duplex. As a control we used an unspecific protein as BSA and heated hnRNP 
A1 before incubation with the iM (20 min, 95 °C). In both cases the fluorescence of the donor did not increase, as 
expected (Fig. 5A).
To further support the finding that hnRNP A1 disrupts the iM, we carried out FRET-melting experiments, rea-
soning that the iM would not give its typical melting profile when bound to hnRNP A1. Fig. 5B shows that hras-1Y 
iM in 50 mM sodium cacodylate, pH 5.5, 50 mM KCl has a TM ~ 50 °C. In the presence of 4 equivalents (r = 4) of 
Figure 5. (A) FRET spectra of 200 nM hras-1Y treated with increasing amounts of purified hnRNP A1 at pH 
5.5, 50 mM sodium cacodylate, 50 mM KCl. As a control BSA and denatured hnRNP A1 (A1 Δ ) have been used. 
Note that hnRNP A1 causes a dramatic increase of the 520 nm donor emission. The emission spectra of hras-1Y 
hybridized to its complementary strand to yield the duplex is reported. Insight shows the energy transfer (ET) 
between donor-acceptor as a function of hnRNP A1 concentrations; (B) FRET-melting of hras-1Y incubated 
with increasing amounts of hnRNP A1 (r = 1–7). The protein abrogates the melting profiles; (C) Cartoon 
showing the melting of hras-1Y bound to its complementary strand or to hnRNP A1 (r = 1–7); (D) –dRFU/
dT versus T curves of hras-1Y alone, hras-1Y+ protein, hras-1Y in duplex, i.e. hybridized to its complementary 
strand.
www.nature.com/scientificreports/
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BSA or denatured hnRNP A1, the melting profile of hras-1Y did not change, as expected. In contrast, when the hras-
1Y iM was incubated with increasing amounts of native hnRNP A1 (r = 1–7), its melting profile strongly changed, 
in keeping with the fact that hras-1Y bound to the protein is not in the iM conformation. It is worth noting that free 
hras-1Y melts with an increasing sigmoidal curve, whereas hras-1Y bound to hnRNP A1 melts with a decreasing 
sigmoidal curve (Fig. 5B). A melting profile similar to that of the hras-1Y:hnRNP A1 complex is obtained with 
hras-1Y in the duplex conformation with its complementary strand, where the two fluorophores are separated by 
~86 Å. Upon melting, the duplex releases the hras-1Y strand which, thanks to its flexibility, will have an end-to-end 
distance < 86 Å (Fig. 5C). This results in a decreasing sigmoidal melting curve, and thus in a –dRFU/dT versus T 
curve marked by a positive peak. In the same way, hras-1Y bound to hnRNP A1 is more extended than when it is 
free. Therefore, also the complex gives a decreasing melting curve and a first derivative curve with a positive peak 
at ∼ 50 °C. The melting of free hras-1Y folded in the iM gives an increasing melting curve and a –dRFU/dT versus 
T curve with a negative peak (Fig. 5D). Summing up, both FRET titrations and melting provide strong evidence 
that hnRNP A1 unfolds the HRAS iM.
We have also analysed the effect of hnRNP A1 on the hras-2Y iM. We found that the protein unfolds the iM 
of hras-2Y at higher r values, as the iM formed by hras-2Y has a higher stability than the hras-1Y iM (58.7 versus 
52.1 °C, at pH 5.5) (S3).
The effect of hnRNP A1 on the HRAS iMs was also investigated by CD (Fig. 6). At pH 5.5, hras-1Y and hras-2Y 
show the typical strong ellipticity at 287 nm of the iM conformation. When the iMs are thermally denatured, the 
positive 287 nm ellipticity drops dramatically. This is a hallmark of the transformation of iM into ssDNA. A similar 
spectral change was obtained when we added increasing amounts of hnRNP A1 (r = 1, 2, 3, 4) to the iMs. HnRNP 
A1 causes a progressive reduction of the 287 nm ellipticity, indicating that the iM structures are unfolded by the 
protein. As already observed with the FRET experiments, the unfolding effect is stronger with hras-1Y than with 
hras-2Y, owing to the different stability of the two iMs.
Insights into the binding of hnRNP A1 to the hras-1Y iM. Clues to the binding mode of hnRNP A1 to 
the iM can be obtained from the co-crystal structure of UP1 (the N-terminus of hnRNP A1 with DNA binding 
activity) and the human telomeric sequence d(TTAGGG)243. The co-crystal shows that a protein dimer binds to 
two single-stranded strands, in the antiparallel orientation. As the two binding domains (RRM1 and RRM2) within 
each protein molecule are also antiparallel, the 5′ → 3′ polarity of ssDNA with respect to the RRM orientation is the 
same for each RRM. The two lateral loops of the iM may (after a minor adjustment) provide suitable binding sites 
for hnRNP A1, as they are antiparallel and separated by ~15–20 Å. So, the iM’s main function should be to provide 
a rigid chemical frame displaying two lateral loops with the precise nucleic acid directionality with respect to the 
RRM orientation. In other words, the iM structure should offer a kinetic advantage to the binding of hnRNP A1 
(indeed, when the iM is disrupted, the binding is strongly attenuated, Fig. 4C). If we assume that the protein binds 
to the lateral loops, it can form either a 1:1 or a 1:2 complex, depending whether one or two protein molecules bind 
to the iM. The equilibria occurring in solution are: P + iM = P•iM (4); P + P•iM = (P)2•iM (5), where P is hnRNP 
A1. In the presence of a large excess of P compared to iM (1:100), both equilibria shift to the right forming complex 
1:2. In contrast, with less P (ratio 1:50) equilibrium (5) does not shift to the right and only complex 1:1 is formed 
(Fig. 7A, lanes 1–3). In addition, as hnRNP A1 unfolds the iM, its binding depends on temperature: at 0 °C only 
complex 1:1 is formed probably because it requires a partial unfolding of iM, at 37 °C complex 1:2 is favoured as it 
requires a complete opening of the iM (S4). To support the binding of the protein to the lateral loops we performed 
the following competition experiment. As the two lateral loops of the hras-1Y iM are separated by 10 nt, complex 
1:2 should be competed by an oligonucleotide containing the two lateral-loop binding sites separated by a spacer of 
10 nt (with a 10 nt spacer the competitor assumes a U-shape so that two antiparallel binding sites can interact with 
the protein RRMs). Moreover, if the spacer of the competitor is reduced to 8, 6, 4, and 2 nt, its capacity to compete 
with the formation of the 1:2 complex should gradually become weaker. To test this hypothesis we designed the 
competitors shown in Fig. 7C. When the competitors (150-fold in excess over iM) were incubated with the iM and 
hnRNP A1 (100-fold over iM), we found that the best competitor was the oligomer containing a spacer of 10 nt, 
Figure 6. Circular dichroism analysis of 3 μM (0.5 cm pathlength cell) hras-1Y and hras-2Y at pH 5.5, 50 mM 
Tris-acetate, 50 mM KCl, after incubation with increasing amounts of hnRNP A1 (r = 0–4) . Spectra of DNA-
protein complex have been subtracted of protein spectrum.
www.nature.com/scientificreports/
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which corresponds exactly to the distance of the lateral-loop binding sites in the wild-type hras-1Y iM. These data 
support the binding of hnRNP A1 to the lateral loops of the iM, as observed for hnRNP LL and BCL2 iM6. As 
stated above, the iM facilitates the initial binding to hnRNP A1. Then, after the iM is unfolded, the protein should 
bind more stably to the iM sequence.
HnRNP A1 knockout results in downregulation of HRAS transcription in human bladder cancer 
cells. As hnRNP A1 binds to the critical GC-elements of the HRAS promoter, we asked if the protein plays a 
role in transcription. We therefore evaluated the effect on transcription of knocking out hnRNP A1 by shRNA. 
First, we determined by quantitative real-time PCR the efficiency of shRNA to knock out hnRNP A1, finding that 
hnRNP A1 mRNA (normalized by the transcripts of β 2-microglobulin and hypoxanthine guanine phosphor-
ibosyltransferase, HPRT) was reduced to 29 ± 8% of the control (cells untreated or treated with a non-specific 
shRNAC), 48 h after treatment (Fig. 8A). In the same cells we also measured the level of HRAS mRNA finding 
that when hnRNP A1 is knocked out, the HRAS transcription is also down-regulated to 44 ± 5% of control. This 
suggests that hnRNP A1 is an essential factor for transcription, as previously reported41. Further evidence that the 
proteins recognizing the iMs of HRAS are essential for transcription was obtained with decoy oligonucleotides 
mimicking hras-1Y iM. These molecules, once introduced in the cells, should sequester the proteins (hnRNP 
A1 included) recognizing the C-rich strand of the HRAS GC-elements. To increase their nuclease resistance, 
the decoy oligonucleotides, namely 5291–5294 (see Methods), have been designed with unlocked nucleic acid 
(UNA) modifications (Fig. 8B) (S5)44,45. The capacity of the UNA-modified oligonucleotides to inhibit HRAS 
transcription was investigated by quantitative real-time PCR. T24 bladder cancer cells were transfected with the 
decoy oligonucleotides as well as with wild-type hras-1Y, using as transfecting agent jet-PEI46. After an incuba-
tion of 24 h, the total cellular RNA was extracted and the amount of HRAS mRNA relative to the housekeeping 
HPRT mRNA was evaluated by qRT-PCR (Fig. 8C). The results showed that oligonucleotides 5292 and 5293 
reduced HRAS mRNA to ~50% of the control (untreated cells). We also examined by electrophoresis the nuclease 
resistance of the decoy oligonucleotides (Fig. 8D). The oligonucleotides were incubated in cell cultured medium 
containing 10% fetal bovine serum at 37 °C, pH 5.5 for 0, 18, 24 and 48 h. While hras-1Y was quickly degraded, 
the UNA-modified oligonucleotides, in particular 5292 and 5293, showed a remarkable stability, as the fraction 
of unbroken oligonucleotide was > 0.5, after 48 h of incubation. Interestingly, the enhanced activity shown by 
these compounds correlates nicely with their higher stability in serum.
Conclusion
We have demonstrated that two neighbouring GC-rich elements controlling HRAS expression can form non 
B-DNA iM structures, which are stable under near-physiological conditions. These unusual DNA structures are 
recognized by hnRNP A1, one of the most abundant nuclear proteins involved in the biogenesis of RNA. We have 
discovered that hnRNP A1 has a clear unfolding activity against the iM. As the knockout of hnRNP A1 by shRNA 
in T24 bladder cancer cells results in the inhibition of HRAS, hnRNP A1 behaves as an activating transcription 
factor. Our data, together with those of Hurley and co-workers, who showed that hnRNP LL binds to the iM of 
Figure 7. (A) 5% PAGE, lanes 4–8 show how the binding of hnRNP A1 to hras-1Y–dy781 (Methods) (ratio 
1:100) at pH 5.5 is competed by oligonucleotides 2-nt - 10-nt (150-fold over iM). Lanes 1–3 shows the binding 
of iM to hnRNP A1 at ratios 1:50, 1:75, 1:100. Experimental conditions: DNA and protein incubated for 40 min 
at 37 °C, pH 5.5 before 5% PAGE analysis; (B) structure of the iM with the two lateral loops to which the protein 
is expected to bind; (C) sequences of the oligonucleotide competitors 2-nt, 4-nt, 6-nt, 8-nt, 10-nt.
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the BCL2 promoter and activates transcription6, provide the first evidence that non B-DNA iM structures are 
recognized by nuclear proteins.
The proteins of the hnRNP family have been associated with the promoter of several genes where they are 
supposed to participate in the transcription regulation mechanisms, although their exact role is not yet fully under-
stood. Some of them recognize C-rich sequences in the promoters of CMYC (hnRNP K)39,40, BCL2 (hnRNP LL)6 
and HRAS (hnRNP A1) (present study). These proteins seem to have a complex binding capacity, as hnRNP A1 is 
also able to bind to G-quadruplex DNA structures in KRAS17 and telomeres47. Remarkably, this type of binding is 
also associated with the disruption of G-quadruplex structures17.
Recent mechanical folding/unfolding experiments showed that G-quadruplex and iM are mutually exclusive 
within the same double-stranded tract48. However, whether this also holds under in vivo conditions, where double 
stranded DNA is exposed to negative superhelicity and located in a molecular crowding environment, has not 
yet been demonstrated. It is possible that both G-quadruplex and iM are extruded from each double-stranded 
GC-element, in the same way as two opposing hairpins (a cruciform) are extruded from a palindromic sequence. 
HRAS could therefore be regulated by a G-quadruplex/iM switch that represses transcription when the structural 
elements are in the folded conformation. Transcription will be activated when hnRNP A1 and MAZ, which rec-
ognize the HRAS G-quadruplexes3, bind to the iM and G-quadruplex, respectively, and then to other proteins of 
the transcriptional activator complex. These non B-DNA structures provide a mechanism for the control of gene 
expression at a different level than duplex, involving proteins recognizing these unusual structures that play a 
central role in gene regulation.
Methods
Oligonucleotides and hnRNP A1. The oligonucleotides used in this study have been obtained from 




5′ -ATTO-CGC GCC CCC GCC CCC GCC CCG CCC C -TAMRA (A-hras-2Y-T)
Figure 8. (A) Real-time determination of hnRNP A1 and HRAS mRNAs after knocking down hnRNP A1 
in T24 bladder cancer cells with a specific shRNA. When hnRNP A1 is knocked down, HRAS mRNA is 
downregulated. P < 0.05 (*); (B) UNA modification introduced in the decoy oligonucleotides; (C) Level of 
HRAS mRNA in T24 cells treated with 200 nM hras-1Y or UNA-modified analogues. Total RNA was extracted 
24 h after oligonucleotide transfection, retro-transcribed and subjected to real time amplification. HRAS mRNA 
expression is normalized with housekeeping gene HPRT. The percentage of residual HRAS mRNA compared 
to HPRT mRNA in each sample is reported. P < 0.05 (*); (D) Resistance in fetal serum of hras-1Y and UNA-
modified analogues. Oligonucleotides have been incubated in serum for 0, 18, 24, 48 and 72 h at 37 °C. After 
incubation the samples have been run in denaturing PAGE, 7 M urea, 55 °C. The gels were stained with “stains all”.
www.nature.com/scientificreports/
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5′ -TCG GGT TGC GGG CGC AGG GCA CGG GCG (hras-1R)
5′ -CGG GGC GGG GCG GGG GCG GGG GCG (hras-2R)
5′ - CGC TCG TGC TCT GCG CTC GCA ACT CGA (hras-1Ym)
5′ - TTTTTGTGTTTTTTTTTGCAATTTTT (ODN-1)
5′ -CGTCCGTGTCCTGCGTCCGCAATCCGA (ODN-2)
5′ -CGCCCGTGCCCTGCGCCCGCAGGGCGA (ODN-3)
5′-Dy 781-TTTTTTTCGCCCGTGCCCGTCGCCCGCAACCCGATTTTTTT-3′ (hras-1Y-dy 781). 
The oligonucleotides with UNA modifications have been synthesized in solid phase as previously 
described44,45: 5′-CGCCCGTGCCCTGuCGCCCGCuAACCCGuA (5291); 5′- CGCCCGTGCCCuUG 
CGCCCuGCAACCCGuA (5292); CGCCCGuUGCCCTGuCGCC-CGCuAACCCGuA (5293) and 
5′-CGCCCGuUGCCCuUGCGCCCuGCAACCCGuA (5294) where uC, uU, uG, uA are unlocked nucleic acid 
nucleotides.
Recombinant hnRNP A1 tagged to GST was obtained with a high degree of purity as previously described49 (S6).
Chromatin immunoprecipitation. T24 urinary bladder cancer cells (1.2 × 106) were cultured overnight 
in 6-cm diameter plates up to about 80% confluency and fixed in 1% formaldehyde in PBS for 5 minutes at room 
temperature to crosslink proteins to DNA. Chromatin immunoprecipitation assays were performed using the 
ChIP-ITTM Express kit (Active Motif, Rixensart, Belgium). Details are reported in S7.
ShRNA transfection, RNA extraction and real-time PCR. T24 cells were plated in 96-well plate (104 
cells/well). After 1 day we transfected the cells with hnRNP A1-specific (sc-35576-SH) and control shRNA (sc-
108066) (Santa Cruz, Dallas, USA) using as transfectant agent jetPEITM (Polyplus, NY, USA). After 48 h, RNA was 
extracted by using iScript TM RT-qPCR sample preparation reagent (BioRad, USA).
For cDNA synthesis, 1.25 μ l of RNA was heated at 70 °C and placed in ice. The solution was added with 7.5 μ l 
of a mix containing (final concentrations) 1 × buffer; 0.01 M DTT (Invitrogen); 1.6 μ M primer dT [MWG Biotech, 
Ebersberg, Germany; d(T)16]; 1.6 μ M random primers; 0.4 mM dNTPs solution containing equimolar amounts 
of dATP, dCTP, dGTP and dTTP (Euroclone, Pavia, Italy); 0.8 U/μ l RNAse OUT; 8 U/μ l of M-MLV reverse tran-
scriptase (Life Technologies, Monza, Italy). The reactions were incubated for 1 h at 37 °C and stopped with heating 
at 95 °C for 5 min. As a negative control the reverse transcription reaction was performed with a sample containing 
DEPC water.
Real-time PCR multiplex reactions were performed with 1xKapa Probe fast qPCR kit for HRAS and house-
keeping genes hypoxanthine-guanine phosphoribosyltransferase (HPRT) and β 2-microglobulin, 2.2 μ l of cDNA 
and primers/probes at the concentrations specified in S1. The PCR cycle was: 3 min at 95 °C, 50 cycles 10 s at 95 °C, 
60 s at 58 °C. Real-time PCR amplification of hnRNP A1 was performed with 1 × Kapa Sybr Fast BioRad iCycle 
qPCR kit (KAPA Biosystems, Wilmington, MA, USA), 300 nM of each primer, 3.5 μ l of cDNA (cycle: 3 min at 
95 °C, 40 cycles 10 s at 95 °C, 30 s at 58 °C). PCR reactions were carried out with a CFX-96 real-time PCR apparatus 
controlled by an Optical System software (version 3.1) (Bio-Rad Laboratories, CA, USA). All expressions were 
normalized with housekeeping genes. The sequences of the primers and probes used for the amplifications are 
given as supplementary data (S8).
CD and FRET experiments. CD spectra have been obtained with a JASCO J-600 spectropolarimeter 
equipped with a thermostatted cell holder. CD experiments were carried out with oligonucleotides hras-1Y and 
hras-2Y (3 μ M) in 50 mM Tris-acetate, pH from 4.5 to 8, 50 mM KCl. Spectra were recorded in 1 or 0.5 cm quartz 
cuvette. A thermometer inserted in the cuvette holder allowed a precise measurement of the sample temperature. 
The spectra have been calculated with J-700 Standard Analysis software (Japan Spectroscopic Co, Ltd) and reported 
as ellipticity (mdeg) versus wavelength (nm). Each spectrum was recorded three times, smoothed and the baseline 
subtracted. CD spectra of 3 μ M hras-1Y and hras-2Y have been obtained also at various temperatures (20-85 °C), 
by both heating and cooling the sample solutions (in 50 mM sodium cacodylate pH 5, 50 mM KCl). By plotting 
the 287 nm ellipticity versus temperature, sigmoidal denaturing and renaturing curves were obtained, which were 
practically overlapping.
FRET with oligonucleotides hras-1Y and hras-2Y, tagged at the 5′ and 3′ ends with ATTO-488 and TAMRA (as 
donor we used ATTO-488 because its pH dependence is weaker than that of FAM), were carried out on a Microplate 
Spectrofluorometer System (Perkin Elmer 2300 Enspire, USA). Each sample contained 50 μ l dual-labelled oligo-
nucleotide (200 nM) in 50 mM Tris-acetate buffer, pH from 4.5 to 8, 50 mM KCl and an amount of hnRNP A1 as 
specified in the figure captions. The samples were incubated at 37 °C as specified in the text. Emission spectra were 
obtained setting the excitation wavelength at 480 nm and recording the emission from 500 to 650 nm. FRET-melting 
experiments of hras-1Y and hras-2Y have been performed on a real-time PCR apparatus (CFX96, BioRad, Hercules, 
CA) in 50 mM sodium cacodylate at pH 5, 5.5, 6, 6.5 and 7, 50 mM KCl. FRET-melting experiments were obtained 
by increasing the temperature from 20 °C to 95 °C (0.3 °C/min). From the melting data we obtained curves reporting 
the fraction of folded iM against temperature. These curves were reversible (denaturing and renaturing curves 
overlapping). The energy transfer (ET) was calculated from the fluorescence intensity of the donor D in the presence 
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IDA and ID were measured in same buffer under identical concentrations (ID was obtained by transforming the 
dual-labeled oligonucleotide into the corresponding duplex in which the fluorophores are at a distance for which 








where R is the distance (Å) and R0 is the Föster distance [defined as the distance at which energy transfer is 50% 
of the maximum value, assumed to be 50 Å50].
Thermodynamic analysis of reversible iM melting curves. The thermodynamic parameters for the 
folding of C-rich sequence into the iM conformation were obtained from the melting curves. From Δ G° = − RT 
ln K = Δ H°–TΔ S° (8) it is obtained lnK = (Δ H°/R)(1/T) + Δ S°/R (9). The equilibrium constant K as a function 
of T is given by K = f/(1–f), where f, the fraction of sequence folded in the iM conformation, is obtained form the 
melting curves. The plot of ln K versus 1/T gives a straight line whose slope (–Δ H/R) and y-intercept (–Δ S/R) 
provide the thermodynamic parameters (S9).
PAGE assays. Oligonucleotides hras-1Y and hras-2Y were end-labelled with [γ -32P]ATP and T4 polynucleotide 
kinase. For competition experiments we used a DNA chemically labelled to dy-781. Before EMSA, the iM-forming 
oligonucleotides were allowed to form their structure in 50 mM Tris–acetate, pH 5.5, 50 mM KCl, (overnight 
incubation at room temperature). Radiolabelled oligonucleotides (10 nM) were incubated for 30 min at 20 °C with 
increasing amounts of hnRNP A1 (0–12 μ g) as specified in Fig. 4B, in 50 mM Tris–acetate, pH 5.5, 50 mM KCl, 
1 mM DTT, 8% glycerol, 1% Phosphatase Inhibitor Cocktail I (Sigma, Milan, Italy), 5 mM NaF, 1 mM Na3VO4, 
2.5 ng/μ l salmon sperm DNA (binding buffer). After incubation, the reaction mixtures were loaded in 5% PAGE 
in 50 mM Tris-acetate pH 5.5, thermostatted at 20 °C. After running the gel was dried and exposed to autoradi-
ography (G E Healthcare, Milan) for 16 h at –80 °C. Mobility-shift experiments of cold hras-1Y and hras-2Y have 
been performed on 15% PAGE, 25 mM KCl, at pH 5 (50 mM sodium acetate) or pH 7 (50 mM Tris-acetate), 20 °C. 
20% PAGE in denaturing 7 M urea conditions, was carried out in TBE. The gels were stained with “stains-all” dye. 
Competition assay with 28 nM hras-1Y-dy781 were performed at 37 °C with 3 μ M of hnRNP A1 (100-fold over iM 
hras-1Y-dy781) and competitor oligonucleotides (150-fold over iM) in 50 mM Tris-acetate, pH 5.5, 50 mM KCl, 
1 mM EDTA, 2.5ng/μ l Salmon sperm. After incubation, the reaction mixtures were loaded in 5% PAGE 1xTBE, 
thermostated at 20 °C. After running the gel was analysed by Odyssey CLx scanner /ImageStudio Software (Li-Cor 
Biosciences).
Cell culture and transfections. T24 human urinary bladder cancer cells were maintained in exponential 
growth in Dulbecco’s Modified Eagle’s Medium (DMEM) containing 100 U/ml penicillin, 100 mg/ml streptomycin, 
20 mM L-glutamine and 10% fetal bovine serum (Euroclone, Milan, Italy).
For transfection we plated 10000 cells for each well in a 96 well plate and transfected using Jet PEI (Polyplus 
Illkirch FRANCE) following manufacturers in vitro protocol for DNA oligonucleotides transfection with 400 nM 
oligonucleotide (48 pmol) and N/P = 3.
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